AbCellera

📍 Vancouver, Canada🗓 Founded 2012👥 600 employees💰 Last funded 2019
Biotechnology Research🌐 abcellera.com
Website LinkedIn
AbCellera discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera’s engine integrates technology, data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems. AbCellera is focused on advancing an internal pipeline of first-in-class and best-in-class programs and collaborating on innovative drug development programs with partners.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2012
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Canada
1
Frequently asked questions
Who invested in AbCellera?
AbCellera has 1 investors on record on gritt.io and 1 late-stage investors.
When did AbCellera last raise funding?
The most recent investment in AbCellera recorded on gritt.io was in 2019.
When was AbCellera founded?
AbCellera was founded in 2012.
What industry is AbCellera in?
AbCellera operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is AbCellera based?
AbCellera is headquartered in Vancouver, Canada.